Dynamic Interactions between a Silica Sphere and Deformable Interfaces in Organic Solvents Studied by Atomic Force Microscopy.

Recent studies have successfully measured surface forces using atomic force microscope (AFM) and modelled surface deformations using the Stokes-Reynolds-Young-Laplace (SRYL) equations for particle-droplet, particle-bubble, droplet-droplet and bubble-bubble systems in various solutions. The current work focuses on interactions between spherical silica particles and a viscoelastic interface of water droplets in crude oil. The self-assembly of surface active natural polyaromatic molecules (NPAMs) at the oil-water interface has previously been shown to change a viscous dominant oil-water interface to an elastic dominant interface, with interfacial aging due to gradual formation of rigid interfacial networks. AFM was used to measure the interactions between a small silica sphere (D ≈ 8 µm) and a deformable water droplet (D ≈ 70 µm), which exhibits time-dependent interfacial viscoelasticity in NPAM solutions. Unlike the systems studied previously, the measured deformation shown as a repulsive force over the constant compliance could not be modelled adequately by the conventional SRYL equations which are applicable only to purely Laplacian interfaces. As the water droplet ages in NPAM solutions, a rigid "skin" forms at the oil-water interface, with the interface exhibiting increased elasticity. Over a short aging period (up to 15 min), interfacial deformation is well predicted by the SRYL model. However upon further exposure to the NPAM solution, droplet deformation is under predicted by the model. Physical properties of this mechanical barrier as a function of time were further investigated by measuring interfacial tension, dilatational rheology and interfacial "crumpling" (non-smooth interface) upon droplet volume reduction. By introducing a viscoelasticity parameter to account for interfacial stiffening, we are able to correct this discrepancy and predict droplet deformation under AFM cantilever compression using experimentally-determined elasticity. This parameter appears to be important for modelling non-Laplacian systems with significant viscoelastic contributions, such as biological cell membranes or polymer blends

New fabrication approach to ZnO multiple nanofiber sensors

In the presented work, ZnO nanofiber sensor structures designed and fabricated using a standard microelectronic device technology were studied. The structures in the configuration of a resistor with chemically active ZnO multiple nanofibers deposited by electrospinning method were prepared. Investigation of inclusion in the process reactive- ly sputtered AlN insulating film to improve the robustness of the nanofibres on the substrate was undertaken. Selective wet chemical etching of AlN film using photoresist developers and a photoresist mask to define the sensor active area was studied. The Ti/Au ohmic contacts were fabricated using the lift-off photolithography process. To- pography of the sensor structure details was investigated using AFM. Electrical charac- terization by means of I-V measurements was made. Sensitivity to the physiologically relevant concentration of Bovine Serum Albumin in water solution was shown. When you are citing the document, use the following link http://essuir.sumdu.edu.ua/handle/123456789/2058

Wigner transform and pseudodifferential operators on symmetric spaces of non-compact type

We obtain a general expression for a Wigner transform (Wigner function) on symmetric spaces of non-compact type and study the Weyl calculus of pseudodifferential operators on them

Formation and tribology of fucoidan/chitosan polyelectrolyte multilayers on PDMS substrates

Polysaccharide polyelectrolyte multilayers (PEMs) based on fucoidan and chitosan were formed by Layer-by-Layer (LbL) assembly on polydimethylsiloxane (PDMS) substrates. The surface and aqueous lubrication properties of the PEM films are evaluated for two types of fucoidan extracted from separate seaweed species (Fucus vesiculosus – FV and Undaria pinnatifida – UP). Zeta potential and atomic force microscopy (AFM) imaging reveal that the PEM layers are formed with consistent charge reversal as each polysaccharide layer is adsorbed to the PDMS substrate, and that there is an associated increase in thickness of the multilayer. The multilayers containing FV fucoidan are found to be thicker than those containing UP fucoidan. Soft tribology measurements using matching PDMS tribo-pairs are used to show that the films are robust under rolling/sliding contacts and effective under aqueous lubricating conditions. The friction in the boundary lubrication regime is substantially decreased (relative to native hydrophobic PDMS) by the presence of the multilayers, with some dependence on whether fucoidan or chitosan is in the outer layer (5 or 5.5 bilayers) for FV fucoidan. The lowest friction coefficient is obtained for the multilayer with the thickest (and likely most hydrated) coating – the (FV/chitosan) 5.5 bilayer system. The results suggest that PEMs involving naturally derived polysaccharides such as fucoidan, which has notable antimicrobial properties and is resistant to enzymatic degradation, may provide opportunities in surface coating design in biomaterials applications for friction reduction

A phase 2 trial investigating the efficacy and safety of the mPGES-1 inhibitor vipoglanstat in systemic sclerosis-related Raynaud's

OBJECTIVE: Our objective was to test the hypothesis, in a double-blind, placebo-controlled study that vipoglanstat, an inhibitor of microsomal prostaglandin E synthase-1 (mPGES-1) which decreases prostaglandin E2 (PGE2) and increases prostacyclin biosynthesis, improves RP.METHODS: Patients with systemic sclerosis (SSc) and ≥7 RP attacks during the last screening week prior to a baseline visit were randomised to four weeks treatment with vipoglanstat 120 mg or placebo. A daily electronic diary captured RP attacks (duration and pain) and Raynaud's Condition Score, with change in RP attacks/week as primary end point. Cold challenge assessments were performed at baseline and end of treatment. Exploratory endpoints included patients' and physicians' global impression of change, Assessment of Scleroderma-associated Raynaud's Phenomenon questionnaire, mPGES-1 activity, and urinary excretion of arachidonic acid metabolites.RESULTS: Sixty-nine subjects received vipoglanstat (n = 33) or placebo (n = 36). Mean weekly number of RP attacks (baseline; vipoglanstat 14.4[SD 6.7], placebo 18.2[12.6]) decreased by 3.4[95% CI -5.8;-1.0] and 4.2[-6.5;-2.0] attacks per week (p= 0.628) respectively. All patient reported outcomes improved, with no difference between the groups. Mean change in recovery of peripheral blood flow after cold challenge did not differ between the study groups. Vipoglanstat fully inhibited mPGES-1, resulting in 57% reduction of PGE2 and 50% increase of prostacyclin metabolites in urine. Vipoglanstat was safe and well tolerated.CONCLUSION: Although vipoglanstat was safe, and well tolerated in a dose achieving full inhibition of mPGES-1, it was ineffective in SSc-related RP. Further development and evaluation of vipoglanstat will therefore be in other diseases where mPGES-1 plays a pathogenetic role.</p

Capric Acid Secreted by S. boulardii Inhibits C. albicans Filamentous Growth, Adhesion and Biofilm Formation

Candidiasis are life-threatening systemic fungal diseases, especially of gastro intestinal track, skin and mucous membranes lining various body cavities like the nostrils, the mouth, the lips, the eyelids, the ears or the genital area. Due to increasing resistance of candidiasis to existing drugs, it is very important to look for new strategies helping the treatment of such fungal diseases. One promising strategy is the use of the probiotic microorganisms, which when administered in adequate amounts confer a health benefit. Such a probiotic microorganism is yeast Saccharomyces boulardii, a close relative of baker yeast. Saccharomyces boulardii cells and their extract affect the virulence factors of the important human fungal pathogen C. albicans, its hyphae formation, adhesion and biofilm development. Extract prepared from S. boulardii culture filtrate was fractionated and GC-MS analysis showed that the active fraction contained, apart from 2-phenylethanol, caproic, caprylic and capric acid whose presence was confirmed by ESI-MS analysis. Biological activity was tested on C. albicans using extract and pure identified compounds. Our study demonstrated that this probiotic yeast secretes into the medium active compounds reducing candidal virulence factors. The chief compound inhibiting filamentous C. albicans growth comparably to S. boulardii extract was capric acid, which is thus responsible for inhibition of hyphae formation. It also reduced candidal adhesion and biofilm formation, though three times less than the extract, which thus contains other factors suppressing C. albicans adherence. The expression profile of selected genes associated with C. albicans virulence by real-time PCR showed a reduced expression of HWP1, INO1 and CSH1 genes in C. albicans cells treated with capric acid and S. boulardii extract. Hence capric acid secreted by S. boulardii is responsible for inhibition of C. albicans filamentation and partially also adhesion and biofilm formation

Neuronal characteristics of small-cell lung cancer

Wide ranging experimental evidence suggests that human small-cell lung cancer (SCLC) has a number of molecular and subcellular characteristics normally associated with neurones. This review outlines and discusses these characteristics in the light of recent developments in the field. Emphasis is placed upon neuronal cell adhesion molecules, neurone-restrictive silencer factor, neurotransmitters/peptides and voltage-gated ion, especially Na+ channels. The hypothesis is put forward that acquisition of such characteristics and the membrane ‘excitability' that would follow can accelerate metastatic progression. The clinical potential of the neuronal characteristics of SCLC, in particular ion channel expression/activity, is discussed in relation to possible novel diagnostic and therapeutic modalities

Sophorolipid biosurfactants: Possible uses as antibacterial and antibiofilm agent.

Biosurfactants are amphipathic, surface-active molecules of microbial origin which accumulate at interfaces reducing interfacial tension and leading to the formation of aggregated micellular structures in solution. Some biosurfactants have been reported to have antimicrobial properties, the ability to prevent adhesion and to disrupt biofilm formation. We investigated antimicrobial properties and biofilm disruption using sophorolipids at different concentrations. Growth of Gram negative Cupriavidus necator ATCC 17699 and Gram positive Bacillus subtilis BBK006 were inhibited by sophorolipids at concentrations of 5% v/v with a bactericidal effect. Sophorolipids (5% v/v) were also able to disrupt biofilms formed by single and mixed cultures of B. subtilis BBK006 and Staphylococcus aureus ATCC 9144 under static and flow conditions, as was observed by scanning electron microscopy. The results indicated that sophorolipids may be promising compounds for use in biomedical application as adjuvants to other antimicrobial against some pathogens through inhibition of growth and/or biofilm disruption